A POC CLINICAL TRIAL FOR PTSD WITH A FIRST-IN-CLASS VASOPRESSIN 1A RECEPTOR ANTAGONIST

$2,009,434FY2015Department of the ArmyDOD

Azevan Pharmaceuticals Inc.

Investigators

A POC CLINICAL TRIAL FOR PTSD WITH A FIRST-IN-CLASS VASOPRESSIN 1A RECEPTOR ANTAGONIST · GrantIndex